Trusted Market Leader for Life Sciences
Analytics & AI Agents

The Challenge

Why Rare Disease Diagnosis Demands Reinvention 

Delayed Detection

Fragmented genomic, proteomic, and transcriptomic datasets slow discovery 

Disconnected Referrals

Tools are built for coders—not for researchers 

Limited Access to Experts

Analysts are overburdened with manual, repetitive queries 

Outdated Clinical Systems

Collaboration is limited by siloed systems and data visualization gaps 

The need: explainable, real-time AI that supports early and equitable diagnosis 

Book a demo
Deep Diagnose 

Ontology-Powered Precision, Embedded in Clinical Workflows 

Deep Diagnose uses AI to detect rare genetic disorders early by matching symptoms to 75M+ clinical associations within the EHR.
Ontology-Driven AI Mapping
EHR-Compatible Integration
Real-Time Updates
Explainable AI
Equitable Reach
7,500+ Rare Disease Predictions

From Trials to Trust

Commercial Documentation

  • Promotional content (emails, ads, landing pages)
  • Branding collateral & campaign copy
  • Sales enablement decks & one-pagers

Clinical Documentation

  • Trial protocols and investigator brochures
  • Patient communication drafts
  • Site letters and deviation narratives

Medical Access

  • GVD documentation – first draft creation with ~ 60% reduction in time
  • Evidence summaries & payer-ready value stories
  • Manuscript sections and compliance-ready decks
Know More

Commercial Impact That Matters

Transforming the Diagnostic Journey for Rare Conditions 
Cuts diagnostic timelines by 60–70% for rare diseases 
Improves early interception through AI-powered clinical triage 
Reduces misdiagnosis costs from fragmented specialty referrals
Expands access to genetic expertise in underserved care settings 
Supports equitable, evidence-based rare disease care across systems 

Who We Serve

On the journey from Molecule to Medicine, we fast-track innovation across the pharma value chain

Drug Discovery

Uncover novel therapies faster with predictive insights, target validation, and repurposing capabilities
Explore More

Clinical Development

Optimize protocol design, site selection, and patient outcomes through AI-enabled clinical development platforms
Explore More

Commerical

Maximize field force impact and personalize HCP/patient journeys with real-time insights
Explore More

Manufacturing & Supply Chain

Drive operational efficiency, traceability, and demand forecasting with intelligent, connected supply chain solutions
Explore More

Medical Affairs

Transform scientific knowledge into strategic advantage, accelerating real-world impact through precision insights and next-gen medical intelligence
Explore More

Patient & HCP Engagement

Redefine patient and provider relationships with hyper-personalized, data-powered engagement that drives loyalty, trust, and results
Explore More

Regulatory Affairs

Turn regulatory complexity into opportunity, accelerating approvals and reducing risk through smart automation and agile compliance strategies
Explore More

Featured News and Insights

See more insights
case study
January 20, 2025
Development and Evaluation of New Liver Donor Risk Index

Devlopment and Evalution of New Liver Donor Risk Index

blog
February 18, 2025
AI Agents in Drug Discovery: Accelerating the Path from Target to Therapy

Drug discovery is a complex, multi-step process that involves identifying disease mechanisms, finding promising compounds, and optimizing leads for clinical trials. At Agilisium, we leverage Gen AI, predictive analytics, and computational chemistry to streamline this journey. Our AI-driven solutions enhance literature review, target identification, data accuracy, and drug repurposing, ultimately reducing time, cost, and risks associated with drug development. Explore how our AI-powered agents are transforming the future of drug discovery.

whitepaper
May 1, 2025
Shaping the Future of Clinical Trials: AI’s Evolving Role in Smarter Study Design and Recruitment

Today’s clinical trial landscape demands smarter, faster, and more patient-centric solutions. In this exclusive whitepaper, Agilisium explores how Artificial Intelligence (AI) is reshaping early-stage study design and recruitment - reducing timelines, cutting costs, and improving trial outcomes. This Whitepaper explores how AI-driven innovations like predictive modeling, synthetic control arms, digital twins, and decentralized recruitment strategies are addressing the biggest challenges in early-phase trials.

podcast
September 24, 2025
Building the AI Playbook for Clinical Trials

Stephen Pyke of Parexel joins Life Sciences DNA to discuss AI adoption in clinical trials, ROI, change management, and the future of agentic AI.

Events
June 20, 2025
Pharma CXO Roundtable 2025

Advancing Life Sciences Business Process Innovation Using Autonomous Agentic Al

Webinars
March 21, 2025
Women Shaping the Future of Pharma & Tech

In celebration of Women’s Day, Agilisium is hosting a special edition of our Women’s Thought Leadership Series—a high-impact panel discussion on “Women Shaping the Future of Pharma & Tech”.

GET STARTED

Unleash Seamless

Data Management

Transform your Analytics Challenges into Practical Data Solutions, from Design to Deployment.

SCHEDULE A DEMO